Attached files
Exhibit
32.2
CERTIFICATION
OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, AS
ADOPTED PURSUANT TO SECTION 906
OF
THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Edesa Biotech, Inc. (the
Company) on Form 10-Q for the quarter ended March 31, 2021, as
filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Kathi Niffenegger, Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1.
The Report fully
complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2.
The information
contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.
Date: May 14,
2021
|
By: /s/
Kathi Niffenegger
|
|
Kathi
Niffenegger
|
|
Chief Financial
Officer
|
|
(Principal
Financial Officer)
|